2 suspended. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Suspended 2 |
Follow Hypersensitivity: new trials by email Literature Review of Hypersensitivity trials Research Report on Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis Tapinarof cream, 1%, Vehicle Cream - Atopic Dermatitis | Phase 3 | Suspended | Organon and Co | 187 | 2025-12-29 | 2026-10-05 |
| Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled Busonid (budesonide 200mcg and 400mcg) - Asthma | Phase 3 | Suspended | Ache Laboratorios Farmaceuticos S.A. | 80 | 2019-12-01 | 2019-07-08 |
Asthma (1) · Dermatitis, Atopic (1) · Eczema (1)
Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Bronchial Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dermatitis (1) · Genetic Diseases, Inborn (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Respiratory Hypersensitivity (1) · Respiratory Tract Diseases (1) · Skin Diseases (1) · Skin Diseases, Eczematous (1) · Skin Diseases, Genetic (1) · Skin and Connective Tissue Diseases (1)
Budesonide (1) · tapinarof (1)
Ache Laboratorios Farmaceuticos S.A. (1) · Organon and Co (1)
Brazil (1) · Canada (1) · United States (1)
Elie Fiss (1)